Bruker Stock Forecast
NASDAQ: BRKRIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
Market open · Delayed 15 min · as of Oct 9, 12:57 PM ET
BRKR analyst consensus
Consensus (13 analysts)
buy
Avg. price target
$63.25+7.68%
- Strong buy 2
- Buy 5
- Hold 5
- Sell 1
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 13 Wall Street analysts covering Bruker (2026-10-07), 7 rate the stock a buy or strong buy, 5 rate it a hold and 1 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $63.25, with a high estimate of $80.00 and a low estimate of $50.00. The average target implies upside of 7.7% from the current price of $58.74.
The spread between the highest and lowest targets is 60.0%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for BRKR.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 2 | 15% |
| Buy | 5 | 38% |
| Hold | 5 | 38% |
| Sell | 1 | 8% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $50.00 | -14.88% |
| Average target | $63.25 | +7.68% |
| High target | $80.00 | +36.19% |